Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerPositron emission tomography to assess hypoxia and perfusion in lung cancerPractical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationOpening up the optical imaging window using nano-luciferin.A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations and experimental results.DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging studyGdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approachCombined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditionsTemporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASHResponse of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary resultsHigh-field small animal magnetic resonance oncology studies.The interconnectedness of cancer cell signaling.Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment.An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.Simultaneous PET-MRI in oncology: a solution looking for a problem?Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in MicePattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance ImagingHypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo.DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC.The War on Cancer rages on.Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.Early tumor development captured through nondestructive, high resolution differential phase contrast X-ray imaging.MRI & MRS assessment of the role of the tumour microenvironment in response to therapy.Kinetic modeling in PET imaging of hypoxia.Nitrite induces the extravasation of iron oxide nanoparticles in hypoxic tumor tissue.Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRIAutomation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness.
P2860
Q24628746-6B657DC9-65D5-4F7D-A7FC-13450220E18BQ27026940-104120BB-8E80-4440-87BC-8A54099A4456Q30575110-2CAC57CE-720A-43CF-80C6-BCBAC6732F45Q30596619-3C9EF538-9542-49A1-8A37-DB0674C8B7F1Q30596630-0BC75531-63DB-4AE8-90C3-B8B900C502B7Q30687678-08C383AF-C09F-4D7F-AFEC-C9996425F366Q33496147-55A462A9-4596-4CA4-843F-5D19C07C4D75Q33652622-839858B1-D10F-484F-8EC7-9637F6B01480Q33655366-1A525E1F-9B85-4C35-BE2E-866E5084FE22Q33704904-5ECC09FE-641C-456A-B821-463238F1014CQ33820595-19A76134-BAC9-4FC7-AE2E-8CA64FF15754Q33925417-46D55498-2F03-4D82-B499-2412B6798266Q34151551-F10DBA01-9D1E-4BF6-9921-944922B21730Q34171086-26BFE2A4-58F4-4478-BC3B-CBC7906FF67EQ34177229-D790CF78-BE86-4E5E-80D9-53A1A7742F6AQ34215586-6D8859A3-C858-474C-ADBC-B1B2407C09A5Q34331739-30ED14C7-2F7A-4239-BD8F-E2AB37FF07C6Q34506028-D86C7549-5344-403A-88AB-C6D56519077AQ34552360-15111D12-C17F-41B5-BF32-FF47CA499CF7Q34601310-23D95405-6188-4F53-BCB8-5B6BE1FC4D25Q35312455-72962CE3-F7DF-46CE-AF9F-373AFD2BD37CQ35669733-8D476D42-9FB2-42A2-B1EE-39616E59A89DQ35744761-2B3271F3-51BF-4F9F-BBAB-DEE916BCCA25Q35753251-FB2F3CE7-98A1-4438-A956-42EBB6152279Q35790990-3A2EA93B-EADD-4D76-9743-94552DDAD270Q36173661-9E7E373C-DBFC-43AC-9E07-D40B8800AB65Q36303648-4FCACCEB-456D-4F39-B770-C5EDC5AAB2AEQ36335266-265B38EB-9F13-432F-B32C-423BC1DC53D7Q36956796-58BC8015-1461-4F9B-A851-A481B5E186B0Q37104879-6D53C440-18BC-4FC9-A729-8BEAB7F09599Q37352786-712161CA-A369-47AC-8ACA-89284607A6C6Q37478602-000D5D79-FDA0-4F8B-83C2-0D6AE82FE1B8Q37559704-A73A16B4-EA3A-4AE2-BC42-80CD63091804Q37586513-0BB00ACB-ACAA-4136-87FC-0962C9E3A65BQ37875004-BC51DB23-D852-42CB-8453-4875EE0BCB0FQ38253648-A5AD1DAC-E781-4727-A905-7F10A6E9C561Q38526991-2DCE2E83-E78F-4DFF-B636-B35DD1A715C3Q38603036-5525B40D-725D-41C0-AB5D-B176B225C3A3Q38670392-93FA994D-400E-4DC4-A5F1-37DBEF2FE2ACQ38727633-9E515B2C-E667-4678-A813-B25CA3209C64
P2860
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@en
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@nl
type
label
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@en
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@nl
prefLabel
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@en
Noninvasive multimodality imag ...... tumor model of tumor hypoxia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Noninvasive multimodality imag ...... l tumor model of tumor hypoxia
@en
P2093
Asif Rizwan
C Clifton Ling
HyungJoon Cho
Jason A Koutcher
John L Humm
Mihaela E Lupu
Pat B Zanzonico
P2860
P304
247-59, 2p following 259
P356
10.1593/NEO.81360
P577
2009-03-01T00:00:00Z